Skip to main content
Earnings Labs
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME)

NASDAQ·Healthcare·Biotechnology

$4.65

+4.61%

Mkt Cap $807.13M

Analyst Ratings

Buy

5

Hold

0

Sell

0

Price Target (8 analysts)

$7.50

Range $6.00 – $9.00

Implied Upside

+61.5%

Consensus $7.50 vs current $4.65